Table 1 Clinical, immunological and virological parameters of 27 HIV-1-infected patients who discontinued antiretroviral therapy.
From: Immunological predictors of CD4+T cell decline in antiretroviral treatment interruptions
Characteristic | Values |
|---|---|
N | 27 |
Males | 19 (70%) |
Age in years | 36.7 ± 1.09 (27; 52) |
HCV coinfection | 6 (22%) |
HIV transmission category | |
Intravenous drug user | 4 (15%) |
Homosexual | 11 (41%) |
Heterosexual | 12 (44%) |
Duration of HIV-infection in years | 6.9 ± 0.6 (2; 14) |
Symptomatic HIV disease, non AIDS | 4 (16%) |
Time on HAART in months | 46.6 ± 3.1 (20.7; 95.1) |
HIV-RNA, log10 copies/mL | 4.2 ± 0.2 (2.3; 5.6) |
Maximal HIV-RNA | 4.4 ± 0.2 (2.7; 6.2) |
Time with HIV-RNA < 50 inmonths | 29.3 ± 2.3 (6; 56.2) |
CD4+ T-cell count/μL | |
CD4+ T-cell at HAART initiation | 504 ± 50 (50; 1150) |
% CD4+ T-cell at HAART initiation | 25.2 ± 1.4 (13; 38) |
CD4+ T-cell nadir | 440 ± 42 (50; 1113) |
CD4+ T-cell at study entry, baseline | 959 ± 55 (611; 1973) |
C%D4+ T-cell at study entry, baseline | 39.1 ± 1.5 (28; 56) |
CD4+ T-cell increase on HAART | 486 ± 60 (116; 1397) |
%CD4+ T-cell increase on HAART | 14.6 ± 1.5 (0; 22) |